4.3 Article

Pulmonary Pathology of End-Stage COVID-19 Disease in Explanted Lungs and Outcomes After Lung Transplantation

Journal

AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Volume 157, Issue 6, Pages 908-926

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/ajcp/aqab208

Keywords

COVID-19; Lung; Transplantation; Fibrosis; Pathology

Categories

Ask authors/readers for more resources

This study reports on the clinical course, pulmonary pathology, and outcomes after lung transplantation in three patients with chronic respiratory failure due to postacute sequelae of SARS-CoV-2 infection. The major pathological findings in the lung explants suggest ongoing fibrosis, prominent macrophage infiltration, neoangiogenesis, and microvascular thrombosis.
Objectives Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may develop end-stage lung disease requiring lung transplantation. We report the clinical course, pulmonary pathology with radiographic correlation, and outcomes after lung transplantation in three patients who developed chronic respiratory failure due to postacute sequelae of SARS-CoV-2 infection. Methods A retrospective histologic evaluation of explanted lungs due to coronavirus disease 2019 was performed. Results None of the patients had known prior pulmonary disease. The major pathologic findings in the lung explants were proliferative and fibrotic phases of diffuse alveolar damage, interstitial capillary neoangiogenesis, and mononuclear inflammation, specifically macrophages, with varying numbers of T and B lymphocytes. The fibrosis varied from early collagen deposition to more pronounced interstitial collagen deposition; however, pulmonary remodeling with honeycomb change was not present. Other findings included peribronchiolar metaplasia, microvascular thrombosis, recanalized thrombi in muscular arteries, and pleural adhesions. No patients had either recurrence of SARS-CoV-2 infection or allograft rejection following transplant at this time. Conclusions The major pathologic findings in the lung explants of patients with SARS-CoV-2 infection suggest ongoing fibrosis, prominent macrophage infiltration, neoangiogenesis, and microvascular thrombosis. Characterization of pathologic findings could help develop novel management strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available